The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT)

Journal of Endocrinological Investigation

Volumn 41, Issue 1, 2018, Pages 67-73

  Rossi, M ^a   Taddei, A R ^b   Fasciani, I ^c   Maggio, R ^c   Giorgi, F ^d  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF TUSCIA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Dichlorodiphenyltrichloroethane; Extracellular vesicle; Graves disease; TSH receptor

Indexed keywords

CHLORPHENOTANE; THYROTROPIN RECEPTOR; PESTICIDE;

CELL ACTIVATION; CELL COMMUNICATION; CELL COMPARTMENTALIZATION; CELL INTERACTION; CYTOLOGY; CYTOTOXICITY; DISEASE COURSE; EXOSOME; GRAVES DISEASE; HUMAN; INTERNALIZATION; MEMBRANE MICROPARTICLE; REVIEW; THYROTROPIN RELEASE; ANIMAL; DRUG EFFECT; METABOLISM; THYROID GLAND;

ANIMALS; DDT; EXTRACELLULAR VESICLES; HUMANS; PESTICIDES; RECEPTORS, THYROTROPIN; THYROID GLAND;

EID: 85021149160     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-017-0716-9     Document Type: Review

References (53)

1. Coperchini F, Awwad O, Rotondi M, Santini F, Imbriani M, Chiovato L (2017) Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA). J Endocrinol Invest 40:105–121
2. Metcalf RL (1973) A century of DDT. J Agric Food Chem 21:511–519
3. Tilghman SL, Bratton MR, Segar HC, Martin EC, Rhodes LV, Li M, McLachlan JA, Wiese TE, Nephew KP, Burow ME (2012) Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS ONE 7:e32754
4. Ibhazehiebo K, Koibuchi N (2014) Impact of endocrine-disrupting chemicals on thyroid function and brain development. Expert Rev Endocrinol Metab 9:579–591
5. Brar NK, Waggoner C, Reyes JA, Fairey R, Kelley KM (2010) Evidence for thyroid endocrine disruption in wild fish in San Francisco Bay, California, USA. Relationships to contaminant exposures. Aquat Toxicol 96:203–215
6. Freire C, Koifman RJ, Sarcinelli PN, Rosa AC, Clapauch R, Koifman S (2014) Association between serum levels of organochlorine pesticides and sex hormones in adults living in a heavily contaminated area in Brazil. Int J Hyg Environ Health 217:370–378
7. Boas M, Feldt-Rasmussen U, Main KM (2012) Thyroid effects of endocrine disrupting chemicals. Mol Cell Endocrinol 355:240–248
8. Müller CE, Schiedel AC, Baqi Y (2012) Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development. Pharmacol Ther 135:292–315
9. Gershengorn MC, Neumann S (2012) Update in TSH receptor agonists and antagonists. J Clin Endocrinol Metab 97:4287–4292
10. Tschammer N (2016) Allosteric modulators of the class A G protein coupled receptors. Adv Exp Med Biol 917:185–207
11. Santini F, Vitti P, Ceccarini G, Mammoli C, Rosellini V, Pelosini C, Marsili A, Tonacchera M, Agretti P, Santoni T, Chiovato L, Pinchera A (2003) In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest 26:950–955
12. Rossi M, Dimida A, Dell’anno MT, Trincavelli ML, Agretti P, Giorgi F, Corsini GU, Pinchera A, Vitti P, Tonacchera M, Maggio R (2007) The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor. J Pharmacol Exp Ther 320:465–474
13. Rossi M, Dimida A, Ferrarini E, Silvano E, De Marco G, Agretti P, Aloisi G, Simoncini T, Di Bari L, Tonacchera M, Giorgi F, Maggio R (2009) Presence of a putative steroidal allosteric site on glycoprotein hormone receptors. Eur J Pharmacol 623:155–159
14. De Gregorio F, Pellegrino M, Picchietti S, Belardinelli MC, Taddei AR, Fausto AM, Rossi M, Maggio R, Giorgi F (2011) The insecticide 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane (DDT) alters the membrane raft location of the TSH receptor stably expressed in Chinese hamster ovary cells. Toxicol Appl Pharmacol 253:121–129
15. Calebiro D (2011) Thyroid-stimulating hormone receptor activity after internalization. Annales des Endocrinologie (Paris) 72:64–67
16. Giorgi F, Auletta G (2016) Semiotic tools for multilevel cell communication. Biosemiotics 9:365–382
17. Sellitti DF, Akamizu T, Doi SQ, Kim GH, Kariyil JT, Kopchik JJ, Koshiyama H (2000) Renal expression of two ‘thyroid-specific’ genes: thyrotropin receptor and thyroglobulin. Exp Nephrol 8:235-243
18. Williams GR (2011) Extrathyroidal expression of TSH receptor. Ann Endocrinol (Paris) 72:68–73
19. Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639–650
20. Allgeier A, Offermanns S, Van Sande J, Spicher K, Schultz G, Dumont JE (1994) The human thyrotropin receptor activates G-proteins Gs and Gq/11. J Biol Chem 269:13733–13735
21. Couët J, de Bernard S, Loosfelt H, Saunier B, Milgrom E, Misrahi M (1996) Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain. Biochemistry 35:14800–14805
22. Couët J, Sar S, Jolivet A, Hai MT, Milgrom E, Misrahi M (1996) Shedding of human thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease. J Biol Chem 271:4545–4552
23. Misrahi M, Couet J, Milgrom E (1997) Mechanisms of shedding of a soluble form of the TSH receptor. Ann Endocrinol (Paris) 58:365–369
24. Latif R, Ando T, Davies TF (2004) Monomerization as a prerequisite for intramolecular cleavage and shedding of the thyrotropin receptor. Endocrinology 145:5580–5588
25. Maggio R, Innamorati G, Parenti M (2007) G protein-coupled receptor oligomerization provides the framework for signal discrimination. J Neurochem 103:1741–1752
26. Scarselli M, Annibale P, McCormick PJ, Kolachalam S, Aringhieri S, Radenovic A, Corsini GU, Maggio R (2016) Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: methods, dynamics and biological function. FEBS J 283:1197–1217
27. Giorgi F, Bruni LE, Maggio R (2010) Receptor oligomerization as a process modulating cellular semiotics. Biosemiotics 3:157–176
28. Baratti-Elbaz C, Ghinea N, Lahuna O, Loosfelt H, Pichon C, Milgrom E (1999) Internalization and recycling pathways of the thyrotropin receptor. Mol Endocrinol 13:1751–1765
29. Singh SP, McDonald D, Hope TJ, Prabhakar BS (2004) Upon thyrotropin binding the thyrotropin receptor is internalized and localized to endosome. Endocrinology 145:1003–1010
30. Hoffmann C, Gaietta G, Bünemann M, Adams SR, Oberdorff-Maass S, Behr B, Vilardaga J-P, Tsien RY, Ellisman MH, Lohse MJ (2005) A FlAsH-based FRET approach to determine G protein—coupled receptor activation in living cells. Nat Methods 2:171–176
31. Picchietti S, Belardinelli M, Taddei AR, Fausto AM, Pellegrino M, Maggio R, Rossi M, Giorgi F (2009) Thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane (DDT) prevents internalization of TSH receptor. Cell Tissue Research 336:31–40
32. Cornelia W, Ferguson SSG (2015) Minireview: role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling. Mol Endocrinol 29:814–830
33. 3 muscarinic receptor-mediated insulin release in vitro and in vivo. FASEB J 26:4275–4286
34. Latif R, Ando T, Davies TF (2007) Lipid rafts are triage centers for multimeric and monomeric thyrotropin receptor regulation. Endocrinology 148:3164–3175
35. Del Conde I, Shrimpton CN, Thiagarajan P, López JA (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106:1604–1611
36. Baciu AE, Uyy E, Uică VI, Boteanu RM, Popescu AI, Giulea C, Manda D, Badiu C, Antohe F (2017) Proteomic analysis of plasma molecular markers as predictors of differentiated thyroid cancer. Rom Rep Phys 69:601
37. Muralidharan-Chari V, Clancy JW, Sedgwick A, D’Souza-Schorey C (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123:1603–1611
38. Rodríguez-Muñoz A, Martínez-Hernández R, Ramos-Leví AM, Serrano-Somavilla A, González-Amaro R, Sánchez-Madrid F, de la Fuente H, Marazuela M (2015) Circulating microvesicles regulate treg and th17 differentiation in human autoimmune thyroid disorders. J Clin Endocrinol Metabol 100:E1531–E1539
39. Mobarrez F, Abraham-Nordling M, Aguilera-Gatica K, Friberg I, Antovic A, Pisetsky DS, Jörneskog G, Wallen H (2016) The expression of microvesicles in the blood of patients with Graves’ disease and its relationship to treatment. Clin Endocrinol (Oxf) 84:729–735
40. Vlasov P, Doi SQ, Sellitti DF (2016) FRTL-5 Rat Thyroid cells release thyroglobulin sequestered in exosomes: a possible novel mechanism for thyroglobulin processing in the thyroid. J Tyroid Res 2016:9276402
41. Marinò M, McCluskey RT (2000) Role of thyroglobulin endocytic pathways in the control of thyroid hormone release. Am J Physiol Cell Physiol 279:C1295–C1306
42. Botta R, Lisi S, Pinchera A, Taddei AR, Fausto AM, Giorgi F, Marinò M (2011) Binding, uptake, and degradation of internalized thyroglobulin in cultured thyroid and non-thyroid cells. J Endocrinol Invest 34:515–520
43. Lisi S, Botta R, Rotondo Dottore G, Leo M, Latrofa F, Vitti P, Marinò M (2016) Intracellular retention of thyroglobulin in the absence of the low-density lipoprotein receptor-associated protein (RAP) is likely due to premature binding to megalin in the biosynthetic pathway. J Endocrinol Invest 39:1039–1044
44. Botta R, Lisi S, Rotondo Dottore G, Vitti P, Marinò M (2017) Binding of thyroglobulin (Tg) to the low-density lipoprotein receptor-associated protein (RAP) during the biosynthetic pathway prevents premature Tg interactions with sortilin. J Endocrinol Invest. doi: 10.1007/s40618-017-0668-0. (Epub ahead of print)
45. Hakulinen J, Sankkila L, Sugiyama N, Kaisa Lehti K, Keski-Oja J (2008) Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes. J Cell Biochem 105:1211–1218
46. Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373–383
47. Masci VL, Taddei AR, Gambellini G, Giorgi F, Fausto AM (2016) Microvesicles shed from fibroblasts act as metalloproteinase carriers in a 3D collagen matrix. J Circ Biomark 5:1–11
48. Dahlman T, Grimelius L, Wallin G, Rubin K, Westermark K (1998) Integrins in thyroid tissue: upregulation of a2b1 in anaplastic thyroid carcinoma. Eur J Endocrinol 138:104–112
49. Cayrol F, Díaz Flaqué MC, Fernando T, Yang SN, Sterle HA, Bolontrade M, Amorós M, Isse B, Farías RN, Ahn H, Tian YF, Tabbò F, Singh A, Inghirami G, Cerchietti L, Cremaschi GA (2015) Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells. Blood 125:841–851
50. Davies TF, Latif R (2015) Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies. Expert Opin Ther Targets 19:835–847
51. Tan L, Wu H, Liu Y, Zhao M, Li D, Lu Q (2016) Recent advances of exosomes in immune modulation and autoimmune diseases. J Autoimmun 49:357–365
52. Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7(3):e30679
53. Isola AL, Chen S (2016) Exosomes: the link between GPCR activation and metastatic potential? Front Genet 7:56